Dymicron, Inc.

Dymicron, Inc. is a medical device manufacturer specializing in spinal implants engineered with proprietary Adymite polycrystalline diamond technology. The company's flagship product, Triadyme-C, is an artificial cervical disc designed for total disc replacement (TDR) procedures. Adymite technology delivers exceptional wear resistance (1,000x more wear resistant than cobalt chrome), virtually eliminates wear debris, and provides superior biocompatibility—carbon-based synthetic material with minimal biological reactivity. The Triadyme-C features a tri-lobe design that mimics natural cervical spine motion and is engineered for long-term clinical durability and reliability. The device is supported by clinical research and regulatory pathways including an FDA Investigational Device Exemption (IDE) clinical trial, with first patient enrollment announced January 2026. Dymicron serves the global spine surgical market and maintains international distribution partnerships. The company operates from its headquarters in Orem, Utah, and supports European markets through a German distributor partner (Medddbase GmbH). Adymite material is formed under extreme conditions (1,400°C temperature, 1,000,000 PSI pressure) and represents a novel approach to reducing prosthetic device wear and extending implant longevity.